Julie Gerberding, a 'vaccine optimist,' on Covid-19 and what comes next

Julie Gerberding, a 'vaccine optimist,' on Covid-19 and what comes next

More reads

• Merck’s Julie Gerberding, a ‘vaccine optimist,’ on Covid-19 and what comes next. (STAT)
• Short-sellers set their sights on surging Asia biotech stocks. (Bloomberg)
• A judge rules AbbVie isn’t ‘immunized’ from antitrust claims over its Humira patent dealings. (STAT Plus)
• Medical device startup raises almost $44M to advance a less-invasive treatment for fluid in the brain. (Boston Globe)